Immunovant, Inc.IMVTNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-2.82%
↓ 100% below average
Average (29q)
1335.77%
Historical baseline
Range
High:40733.37%
Low:-743.68%
Volatility
3105.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -2.82% |
| Q2 2025 | -10.94% |
| Q1 2025 | 15.79% |
| Q4 2024 | -2.70% |
| Q3 2024 | -23.33% |
| Q2 2024 | -15.38% |
| Q1 2024 | -44.44% |
| Q4 2023 | 20.00% |
| Q3 2023 | 21.05% |
| Q2 2023 | -23.91% |
| Q1 2023 | 6.12% |
| Q4 2022 | -19.51% |
| Q3 2022 | -17.14% |
| Q2 2022 | 14.63% |
| Q1 2022 | -13.89% |
| Q4 2021 | -2.86% |
| Q3 2021 | -12.90% |
| Q2 2021 | -6.90% |
| Q1 2021 | 9.38% |
| Q4 2020 | -52.38% |
| Q3 2020 | 34.38% |
| Q2 2020 | -10.34% |
| Q1 2020 | -3.57% |
| Q4 2019 | -743.68% |
| Q3 2019 | 173.58% |
| Q2 2019 | 40733.37% |
| Q1 2019 | 99.99% |
| Q4 2018 | -66.67% |
| Q3 2018 | 18.18% |
| Q2 2018 | 0.00% |